Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale. Debuts at AACR Annual Meeting 2026 ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...
Zacks Investment Research on MSN
10x Genomics stock up on Atera launch, spatial biology scale enhanced
10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...
"Singular has built a competitive spatial platform and a strong foundation in a rapidly evolving market," said John Stark, CEO. "I'm excited to build on that momentum - deepening partnerships, scaling ...
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...
Next-generation sequencing (NGS) was developed at the turn of the millennium, and the first complete sequence of the human genome was achieved in 2022. Recent technological developments now allow us ...
Conference talk highlights SPOT-Met, perhaps the world's largest in situ multiomic initiative to-date in colorectal cancer; the company also showcases platform validation data, 1,300-gene plex ...
Flagship challenge will award an in situ multiomic study on G4X up to 1,000 samples, opening the door to larger cohort-based spatial research in oncology and translational science SAN DIEGO, March 26, ...
PLEASANTON, Calif., April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results